Kyverna Therapeutics Stock Performance
as on November 4, 2025 at 2:29 am IST
Day's Low
Day's High
$6.6$7.19
3.79%
Downside
4.81%
Upside
52 Week's Low
52 Week's High
$1.78$8.4574.05%
Downside
23.14%
Upside
Kyverna Therapeutics share price movements today
- Previous Close
- $6.97
- Open
- $7.05
- Volume
- 939.4K
- Day's Low - High
- $6.6 - $7.19
- 52 Week Low - High
- $1.78 - $8.45
Kyverna Therapeutics Historical Returns
- 1 Month Return
- + 24.64 %
- 3 Month Return
- + 104.15 %
- 1 Year Return
- + 33.33 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Kyverna Therapeutics Stock Fundamentals & Key Indicators
Check Kyverna Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$301.4M
EPS (TTM)
-3.778
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-170.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-49.72%
Kyverna Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kyverna Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $301.4M | NA | NA | 0.00% | |
| BUY | $39.7B | 455.58% | -16.34 | -264.83% | |
| BUY | $60.2B | 211.18% | 1425.12 | 1.36% | |
| BUY | $109.1B | 98.06% | 30.31 | 31.86% | |
| BUY | $68.5B | 9.39% | 15.62 | 32.13% |
Stock Returns calculator for Kyverna Therapeutics Stock including INR - Dollar returns
The Kyverna Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kyverna Therapeutics investment value today
Current value as on today
₹1,38,593
Returns
₹38,593
(+38.59%)
Returns from Kyverna Therapeutics Stock
₹32,946 (+32.95%)
Dollar Returns*
₹5,648 (+5.65%)
Analyst Recommendation on Kyverna Therapeutics Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Kyverna Therapeutics. Average target price of $24
Kyverna Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Kyverna Therapeutics.
What analysts predicted
71.42%UPSIDE
Target Price
$24
Current Price
$6.86
Analyzed by
10 Analysts
Target
$24.00
Kyverna Therapeutics target price $24, a slight upside of 71.42% compared to current price of $6.86. According to 10 analysts rating.
Kyverna Therapeutics Stock’s Investor Sentiment and Interest
Search interest for Kyverna Therapeutics Stock has increased by 1000% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1000% versus previous 30 day period
Kyverna Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Kyverna Therapeutics Annual Profit & Loss
All numbers in Millions USD
Kyverna Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Kyverna Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Kyverna Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, KYTX stock has moved up by 24.6%
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 173.5% return, outperforming this stock by 140.2%
About Kyverna Therapeutics
| Organisation | Kyverna Therapeutics |
| Headquarters | 5980 Horton Street, Emeryville, CA, United States, 94608 |
| CEO | Mr. Warner Biddle |
| E-voting on shares | Click here to vote |
Key Management of Kyverna Therapeutics
Name | Title |
|---|---|
Ms. Karen Walker | Chief Technology Officer |
Dr. Marc Grasso M.D. | Chief Financial Officer |
Dr. Tom Van Blarcom Ph.D. | Senior VP & Head of Research |
Ms. Cara Bauer Ph.D. | Chief Human Resources Officer |
Dr. Naji H. Gehchan M.B.A., M.D. | Chief Medical & Development Officer |
Mr. Warner Biddle | CEO & Director |
Mr. Dan Maziasz | Chief Business Officer |
Dr. Sham Dholakia DPHIL, M.D. | Chief Product Officer |
Ms. Tracy Rossin | Senior Vice President of Corporate Affairs & Communications and Investor Relations |
FAQs
What is Kyverna Therapeutics share price today?
Kyverna Therapeutics share price today is $6.86 as on at the close of the market. Kyverna Therapeutics share today touched a day high of $7.19 and a low of $6.6.
What is the 52 week high and 52 week low for Kyverna Therapeutics share?
Kyverna Therapeutics share touched a 52 week high of $8.45 on and a 52 week low of $1.78 on . Kyverna Therapeutics stock price today i.e. is closed at $6.86,which is 18.79% down from its 52 week high and 285.39% up from its 52 week low.
What is Kyverna Therapeutics's market capitalisation today?
Kyverna Therapeutics market capitalisation is $0.00T as on .
How to invest in Kyverna Therapeutics Stock (KYTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kyverna Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyverna Therapeutics Shares that will get you 0.2187 shares as per Kyverna Therapeutics share price of $6.86 per share as on November 4, 2025 at 2:29 am IST.
What is the minimum amount required to buy Kyverna Therapeutics Stock (KYTX) from India?
Indian investors can start investing in Kyverna Therapeutics (KYTX) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Kyverna Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kyverna Therapeutics share’s latest price of $6.86 as on November 4, 2025 at 2:29 am IST, you will get 1.4577 shares of Kyverna Therapeutics. Learn more about
fractional shares .